stay updated with our newsletter

Subscribe
Facebook Twitter Linkedin

Rob Lutz, Founder & Editorial Director

Beyond LDL: Lp(a), Nattokinase, and Niacin

Normal LDL cholesterol does not always mean low cardiovascular risk. In this episode, Rob Lutz talks with Bradley Bush, ND, about why adults should consider having Lipoprotein(a), or Lp(a), measured at least once—and how the result may influence personalized cardiometabolic care. They discuss the genetic basis of Lp(a), niacin and flushing management, liver enzyme monitoring, nattokinase, and practical strategies for supporting cardiovascular health.

Depression, Full-Fat Cheese, and Daylight Savings Time: Three New Studies to Watch

Stay current with the latest findings from across the integrative health world with Research Roundup. This new monthly column is dedicated to distilling evidence into clear, practical context for your clinical practice—what’s promising, what needs a closer look, and what may matter for your patients. Here are a few recentRead

The Effects of Toxic Mold and Their Mycotoxins on the Brain in Children and Adults

How might toxic mold and mycotoxins affect neurological health across the lifespan? Rob Lutz speaks with Dr. Andrew Campbell about the ways mold exposure may affect the body and brain, the role of mycotoxin testing, the importance of identifying and removing exposure sources, and principles for evidence-based care. The conversation includes clinical insights, case examples, and considerations for practitioners.

Galectin-3 and Apheresis: The Future of Medicine

In this webinar, Dr. Eliaz presents groundbreaking research findings and practice-tested protocols to effectively manage Galectin-3, including the use of selective apheresis showing breakthrough results against life-threatening sepsis and other pro-inflammatory conditions. He will also discuss benefits, risks, and common misconceptions related to apheresis.

The Sympathetic Spiral of Doom: Why So Many Patients Stay Stuck

Many patients continue to experience fatigue, anxiety, poor sleep, and low resilience even when conventional testing appears normal. On the One Medicine Podcast, Dr. Scott Scher explores the “sympathetic spiral of doom”—a framework for understanding how mitochondrial dysfunction, oxidative stress, autonomic imbalance, and immune-endocrine signaling may reinforce one another. He explains why energy may need to come first, how treatment can backfire when it is introduced too soon, and how clinicians can better sequence care.